Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1 Suppl
pubmed:dateCreated
2006-7-5
pubmed:abstractText
Pulmonary hypertension (PH) is a life-threatening disease. Bone marrow cell transplantation is reported to reduce the development of PH by increasing vascular beds in pulmonary circulation. However, adenoviral overexpression of endothelial nitric oxide synthase (eNOS) in the lung is also known to reduce PH. Because mesenchymal stem cells (MSCs) are potential cell sources for neovascularization, the implantation of MSCs overexpressing eNOS (MSCs/eNOS) may further improve the surgical results. We evaluated the efficacy of MSCs/eNOS implantation in monocrotaline (MCT)-induced PH rats.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1524-4539
pubmed:author
pubmed:issnType
Electronic
pubmed:day
4
pubmed:volume
114
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
I181-5
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:16820570-Adenoviridae, pubmed-meshheading:16820570-Animals, pubmed-meshheading:16820570-Cells, Cultured, pubmed-meshheading:16820570-DNA, Complementary, pubmed-meshheading:16820570-Disease Models, Animal, pubmed-meshheading:16820570-Femoral Vein, pubmed-meshheading:16820570-Gene Therapy, pubmed-meshheading:16820570-Genetic Vectors, pubmed-meshheading:16820570-Humans, pubmed-meshheading:16820570-Hypertension, Pulmonary, pubmed-meshheading:16820570-Injections, Intravenous, pubmed-meshheading:16820570-Male, pubmed-meshheading:16820570-Mesenchymal Stem Cell Transplantation, pubmed-meshheading:16820570-Monocrotaline, pubmed-meshheading:16820570-Nitric Oxide Synthase Type III, pubmed-meshheading:16820570-Rats, pubmed-meshheading:16820570-Rats, Sprague-Dawley, pubmed-meshheading:16820570-Ventricular Dysfunction, Right
pubmed:year
2006
pubmed:articleTitle
Implantation of mesenchymal stem cells overexpressing endothelial nitric oxide synthase improves right ventricular impairments caused by pulmonary hypertension.
pubmed:affiliation
Department of Thoracic and Cardiovascular Surgery, Osaka Medical College, Osaka, Japan. tho064@poh.osaka-med.ac.jp
pubmed:publicationType
Journal Article, Comparative Study, Evaluation Studies